These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15633234)

  • 1. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population.
    Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
    World J Gastroenterol; 2005 Jan; 11(2):289-92. PubMed ID: 15633234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population].
    Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):76-9. PubMed ID: 15774209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.
    Sümbül AT; Akkız H; Bayram S; Bekar A; Akgöllü E; Sandıkçı M
    Mol Biol Rep; 2012 Feb; 39(2):1639-47. PubMed ID: 21607615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of p53 codon 72 polymorphism with genetic susceptibility to hepatocellular carcinoma in Chinese population].
    Zhu ZZ; Cong WM; Zhu GS; Liu SF; Xian ZH; Wu WQ; Zhang XZ; Wang YH; Wu MC
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):632-5. PubMed ID: 16331559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.
    Huang XH; Sun LH; Lu DD; Sun Y; Ma LJ; Zhang XR; Huang J; Yu L
    World J Gastroenterol; 2003 Apr; 9(4):692-5. PubMed ID: 12679912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between MDM2 SNP309, p53 Arg72Pro, and hepatocellular carcinoma risk: A MOOSE-compliant meta-analysis.
    Duan X; Li J
    Medicine (Baltimore); 2017 Sep; 96(36):e7856. PubMed ID: 28885338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Xu CT; Zheng F; Dai X; Du JD; Liu HR; Zhao L; Li WM
    Asian Pac J Cancer Prev; 2012; 13(9):4305-9. PubMed ID: 23167333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Yoon YJ; Chang HY; Ahn SH; Kim JK; Park YK; Kang DR; Park JY; Myoung SM; Kim DY; Chon CY; Han KH
    Carcinogenesis; 2008 Jun; 29(6):1192-6. PubMed ID: 18390844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arg72Pro polymorphism of p53 may predict poor response to medical treatment in ulcerative colitis.
    Vietri MT; Riegler G; Pellino G; Molinari AM; Cioffi M
    Ann Ital Chir; 2014; 85(6):513-7. PubMed ID: 25712892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
    Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
    Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on the association of MTHFR C677T polymorphism with genetic susceptibility to hepatocellular carcinoma].
    Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):196-8. PubMed ID: 16556414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of 53BP1 and p53 polymorphisms to susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Cao YY; Ge H; Chen LQ; Chen ZF; Wen DG; Li Y; Zhang JH
    Ai Zheng; 2007 Oct; 26(10):1052-7. PubMed ID: 17927872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.
    Shen SQ; Jiang DK; Liu GY; Chen F; Yu L
    Mol Biol Rep; 2012 Apr; 39(4):4683-90. PubMed ID: 21952824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
    Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
    Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.
    Peng Q; Lao X; Chen Z; Lai H; Deng Y; Wang J; Mo C; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
    PLoS One; 2013; 8(12):e82773. PubMed ID: 24376578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma.
    Son MS; Jang MJ; Jeon YJ; Kim WH; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
    Gene; 2013 Jul; 524(2):156-60. PubMed ID: 23632240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Arg72Pro of P53 polymorphism with colorectal cancer susceptibility risk in Malaysian population.
    Aizat AA; Shahpudin SN; Mustapha MA; Zakaria Z; Sidek AS; Abu Hassan MR; Ankathil R
    Asian Pac J Cancer Prev; 2011; 12(11):2909-13. PubMed ID: 22393962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis demonstrates association between Arg72Pro polymorphism in the P53 gene and susceptibility to keloids in the Chinese population.
    Wu Y; Wang B; Li YH; Xu XG; Luo YJ; Chen JZ; Wei HC; Gao XH; Chen HD
    Genet Mol Res; 2012 Jun; 11(2):1701-11. PubMed ID: 22843046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
    Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
    Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases.
    Hu S; Zhao L; Yang J; Hu M
    Tumour Biol; 2014 Apr; 35(4):3647-56. PubMed ID: 24326769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.